Why Antipsychotics Are the Foundation of Schizophrenia Treatment
Antipsychotic medications work primarily by modulating dopamine pathways in the brain — and, in newer medications, serotonin pathways as well. They are the most evidence-based treatment for reducing and managing the positive symptoms of schizophrenia, such as hallucinations and delusions. While they are not a cure, they are a critical tool that helps many people live fuller, more stable lives.
There are two major classes of antipsychotics, commonly referred to as first-generation (typical) and second-generation (atypical) antipsychotics.
First-Generation (Typical) Antipsychotics
Developed in the 1950s, first-generation antipsychotics (FGAs) were the original breakthrough in schizophrenia pharmacotherapy. They primarily block dopamine D2 receptors.
Common Examples
- Haloperidol (Haldol)
- Chlorpromazine (Thorazine)
- Fluphenazine (Prolixin)
- Perphenazine (Trilafon)
Benefits
- Effective at reducing positive symptoms (hallucinations, delusions)
- Long-acting injectable (LAI) formulations available, which can help with medication adherence
- Generally lower cost
Potential Side Effects
- Extrapyramidal symptoms (EPS): Muscle stiffness, tremors, restlessness (akathisia), and involuntary movements
- Tardive dyskinesia (TD): A potentially irreversible movement disorder involving repetitive, involuntary movements — a serious long-term risk with prolonged use
- Sedation and cognitive dulling
Second-Generation (Atypical) Antipsychotics
Introduced in the 1990s, second-generation antipsychotics (SGAs) block both dopamine and serotonin receptors. They were initially marketed as having fewer movement-related side effects, though the reality is more nuanced.
Common Examples
- Risperidone (Risperdal)
- Olanzapine (Zyprexa)
- Quetiapine (Seroquel)
- Aripiprazole (Abilify)
- Clozapine (Clozaril)
- Ziprasidone (Geodon)
- Lurasidone (Latuda)
Benefits
- Generally lower risk of EPS and tardive dyskinesia compared to FGAs
- Some evidence for modest benefit with negative and cognitive symptoms
- Clozapine is specifically indicated for treatment-resistant schizophrenia
Potential Side Effects
- Metabolic effects: Weight gain, elevated blood sugar, and lipid abnormalities (especially with olanzapine and clozapine)
- Sedation
- Prolactin elevation (especially risperidone)
- Clozapine requires regular blood monitoring due to risk of agranulocytosis
Comparing the Two Classes: A Quick Overview
| Feature | First-Generation | Second-Generation |
|---|---|---|
| Primary mechanism | Dopamine D2 blockade | Dopamine + serotonin blockade |
| Movement side effects | Higher risk | Generally lower risk |
| Metabolic side effects | Lower risk | Higher risk (varies by drug) |
| Cost | Often lower | Can be higher (generics available) |
| LAI options | Yes | Yes (several available) |
What to Discuss with Your Prescriber
There is no universally "best" antipsychotic — the right medication depends on an individual's symptom profile, health history, lifestyle, and personal preferences. Important questions to raise with your psychiatrist include:
- What are the most likely side effects for this specific medication?
- How long before I should expect to notice an effect?
- Are there long-acting injectable options that might improve consistency?
- What monitoring (blood tests, weight checks) will be needed?
- What is the plan if this medication doesn't work well enough?
Medication adherence is one of the strongest predictors of stability in schizophrenia. Open communication with a prescriber makes it much easier to stay on a regimen that works.